Pharma major Eli Lilly claims its weight loss drug reduces cardiovascular risks in Type 2 diabetes patients
Eli Lilly's Mounjaro demonstrates significant cardiovascular benefits for Type 2 diabetes patients with heart disease, reducing mortality and cardiovascular risks. The SURPASS-CVOT trial revealed Mounjaro's superiority over Trulicity, showing improvements in A1C levels, weight loss, and renal function. These findings support Mounjaro as a potential front-line therapy, with Lilly planning to submit the results to global regulatory authorities.
Tired of too many ads?
Remove Ads
Tired of too many ads?
Remove Ads
Pharma major Eli Lilly today said that it's weight loss drug Mounjaro has helped in reducing cardiovascular risks in patients with Type 2 diabetes and heart disease.According to the results of the trial which included over 13,000 patients across 30 countries, including India, 16 % reduction in all-cause mortality was seen, 8% lower risk of heart attack, stroke, or cardiovascular death, reinforcing its potential as a breakthrough therapy for Indians living with type 2 diabetes and heart disease.'Lilly's Mounjaro ( tirzepatide ) has shown superior cardiovascular protection over Trulicity in the landmark SURPASS-CVOT global trial,' it said in a statement.The trial also demonstrated significant improvements in A1C (-1.73%) and weight loss (-11.43 kg) for Mounjaro. A1C is a biomarker for Type 2 diabetes.Mounjaro (tirzepatide), a GIP/GLP-1 dual receptor agonist, was compared to Trulicity (dulaglutide), a GLP-1 receptor agonist that showed a definitive cardiovascular benefit in the REWIND study.'In SURPASS-CVOT, Mounjaro achieved the primary objective by demonstrating a non-inferior rate of major adverse cardiovascular events (MACE- 3), including cardiovascular death, heart attack or stroke vs. Trulicity. In addition, Mounjaro showed improvements on key measures of A1C, weight, renal function and all-cause mortality,' it further said.The trial lasted more than four and a half years and is the largest and longest study of tirzepatide to date.'Cardiovascular disease continues to be the leading cause of death among individuals with type 2 diabetes,' said Winselow Tucker, President and General Manager, Eli Lilly and Company (India). 'The SURPASS-CVOT trials highlight that Mounjaro maintains the cardioprotective effects seen with Trulicity, a GLP-1 receptor agonist, while offering additional advantages such as a slower eGFR decline and a lower mortality rate. These results further support Mounjaro's potential as a front-line therapy for people managing both type 2 diabetes and cardiovascular conditions."Doctors say the results of the study will help the company secure label expansions to reduce the risk of cardiovascular issues.The heart-helping benefits of GLP-1 drugs have been well established. Earlier in 2020, lilly's rival Novo Nordisk's Ozempic was approved to reduce cardiovascular risks in Type 2 diabetes patients by the FDA.Lilly said that it will submit the results to the global regulatory authorities by the end of this year. In September, the company will present detailed data from the trial at the European Association for the Study of Diabetes annual meeting in Vienna.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
30 minutes ago
- Time of India
At PGI, new hope to rein in type-2 diabetes
1 2 Chandigarh: Type 2 diabetes mellitus (T2DM) may not be invincible after all. Researchers are exploring the possibility of achieving remission through a combination of medication and lifestyle changes. The study, 'DiaRem-1' – recently published in the 'Indian journal of endocrinology and metabolism' – challenges the traditional view that T2DM is a permanent condition and provides evidence that remission is a feasible goal for some patients. The DiaRem-1 trial was an open-label, randomised controlled study at a single centre in India. It involved adult patients with T2DM of less than five years duration and an HbA1c level below 8.5% All participants were medicated for three months, followed by a three-month off-treatment period to assess for remission. Remission was officially defined as maintaining an HbA1c below 6.5% without any antidiabetic medication for three months. Nearly a third of the patients achieved remission. This small but powerful trial offers a cost-effective and scalable strategy that can work in outpatient clinics across India and the world. "With early, intensive treatment and continued support, many patients may no longer need diabetes medication. That's a powerful message of hope," said Dr Rama Walia, lead investigator of the study, adding: "Physical workout for an hour daily, including brisk walk, yoga or dance, was advised in the trial. Patients were kept on home-based healthy diet." Unlike other methods that rely on intensive, impractical diets or expensive surgeries, this study focused on using modern, widely available medications along with standard dietary and physical activity advice. Doctors now understand that two major culprits drive diabetes progression: glucotoxicity (too much sugar damaging beta cells) and lipotoxicity (fat accumulation impairing insulin action). By reversing these with medication and lifestyle therapy, the pancreas gets a much-needed break and, in some cases, begins to function more normally again. SWEAT & DIET MAY KEEP PILLS AWAY Chandigarh is considered the diabetic capital of India as the prevalence of prediabetes and diabetes is the highest in the country How Test Was Conducted Participants were divided into two groups: Intervention arm: 14 patients received a combination of liraglutide, dapagliflozin, and metformin. Control arm: 15 patients received vildagliptin, glimepiride, and metformin. Definition of Remission: HbA1c <6.5% for at least 3 months without medication Key Findings Remission Rate: 9 of the 29 participants (31%) achieved remission. Four from the intervention arm and five from control arm maintained HbA1c below 6.5% without treatment Weight Loss: Both groups experienced significant weight loss, as well as reductions in fat mass and body fat percentage. Intervention group had a median weight loss of -4.9 kg and the control group -3 kg, No Special Meds: Both modern and standard drugs helped when tightly managed Hope Floats: Not a cure, but a realistic and hopeful path to freedom from drugs Any Predictors Of Success? No baseline characteristics could be identified to predict which patients would achieve remission. However, those who did achieve remission tended to have a shorter duration of diabetes and greater weight loss. What's Next? PGI team is continuing research to test how long remission lasts and whether longer treatment duration might improve outcomes further Get the latest lifestyle updates on Times of India, along with Friendship Day wishes , messages and quotes !
Time of India
4 hours ago
- Time of India
Two further attacks on Indians in Dublin trigger Indian embassy to issue advisory
. LONDON: The Indian embassy in Dublin has issued a stark warning advising Indian citizens in Ireland to take precautions for their personal safety and avoid deserted areas, especially at odd hours, after two more Indian nationals have been brutally attacked and left with serious injuries. The Indians embassy notice said there has been 'an increase in the instances of physical attacks reported against Indian citizens in Ireland recently' and that the embassy was 'in touch with the authorities concerned'. It advised Indian nationals to take "reasonable precautions'. On July 19 in Tallaght, an Indian man was left with blood pouring out of his head, his underwear and trousers removed, after an unprovoked assault by around 10 teenagers who stabbed him in the face multiple times when he was walking to his temple. Then, on July 24, an Indian man, in his 20s, was attacked by a group of teenagers at a tram stop in Dublin at 10.30 pm local time. He was pushed, beaten, and stabbed in the face with a screwdriver and taken to Mater Misericordiae Hospital for treatment of serious injuries. On July 28, Dr Santosh Yadav, a senior data scientist in his 30s, was returning to his apartment in Dublin following dinner when six teenagers attacked him from behind. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Max Estates ₹6 Cr+ Homes In Gurgaon Max Estates - Estate 361 Book Now Undo 'They snatched my glasses, breaking them, and then beat me relentlessly across my head, face, neck, chest, hands, and legs, leaving me bleeding on the pavement,' he said. He managed to call the Gardaí and an ambulance took him to Connolly Hospital Blanchardstown. His cheekbone is fractured, and he has been referred for specialist care. 'Racist attacks on Indian men and other minorities are surging across Dublin — on buses, in housing estates, and on public streets. Yet, the govt is silent. We deserve to walk on the streets without fear,' Yadav said. Three protests were held last week in Dublin calling for an end to racism and justice for Indian victims. A Gardaí spokesperson confirmed the police are investigating all three attacks and said: 'Every hate crime reported to An Garda Síochána is professionally investigated.' S Aditya Mandal, an AI professional from West Bengal, who has been working in Dublin for eight years, told TOI: 'No one has been arrested till now in any of these three attacks. Indians here are feeling scared for their families and many are reconsidering whether they want to stay in Ireland.'
United News of India
5 hours ago
- United News of India
PM pays homage to Pingali Venkayya on birth anniversary
New Delhi, Aug 2 (UNI) Prime Minister Narendra Modi today paid tribute to Pingali Venkayya on his birth anniversary, recalling his contribution in designing the Indian National Flag — the Tricolour, a symbol of the nation's pride and unity. In a message shared on the social media platform X, the Prime Minister urged citizens to bolster the ongoing #HarGharTiranga movement by hoisting the Tricolour at their homes. He encouraged people to upload selfies or photographs with the national flag on the official portal reinforcing the spirit of patriotism. 'Tributes to Pingali Venkayya Ji on his birth anniversary. He is remembered for his role in giving us the Tricolour, which is our pride! Like always, let's strengthen #HarGharTiranga movement and fly the Tricolour. Do upload your selfie or photos on Modi stated. UNI AJ GNK More News One in five Indians to be senior citizens by 2050, NHRC urges culturally rooted policies 02 Aug 2025 | 8:08 PM New Delhi, Aug 2 (UNI) India is projected to have nearly 35 crore elderly citizens by 2050, with one in every five individuals belonging to the senior age group, posing a significant challenge for policymakers across the country, experts said today here at an event. see more.. Nadda sounds alarm on rising organ failures, calls for increased donation awareness 02 Aug 2025 | 7:34 PM New Delhi, Aug 2 (UNI) Union Health Minister JP Nadda today expressed concern over the increasing cases of organ failures, calling it a serious public health challenge that is putting immense pressure on the healthcare system. see more.. PM pays homage to Pingali Venkayya on birth anniversary 02 Aug 2025 | 7:32 PM New Delhi, Aug 2 (UNI) Prime Minister Narendra Modi today paid tribute to Pingali Venkayya on his birth anniversary, recalling his contribution in designing the Indian National Flag — the Tricolour, a symbol of the nation's pride and unity. see more.. Fssai releases list of ayurvedic food formulations under 'Ayurveda Aahara' 02 Aug 2025 | 6:30 PM New Delhi, Aug 2 (UNI) The Food Safety and Standards Authority of India (FSSAI), in consultation with the Union Ayush Ministry has released a definitive list of ayurvedic food preparations under the category of 'Ayurveda Aahara.' These regulations recognise foods based on recipes, ingredients, and processes from authoritative ayurvedic texts, and the new list brings unprecedented clarity and confidence to consumers and businesses alike, said an official statement issued today here. see more.. 02 Aug 2025 | 6:29 PM New Delhi, Aug 2 (UNI) Congress president Mallikarjun Kharge today slammed the BJP and RSS, accusing them of endangering the Constitution by advancing an ideology that contradicts its core principles. see more..
